Ortho Kinematics Pursues Large Market Opportunity in Back Pain Diagnostics
Although back pain is common, it can be difficult for physicians to determine the exact cause of the pain using current testing methods.
low back pain
Isto Gets Go-Ahead for Clinical Study of NuQu
ISTO Technologies has received FDA approval to begin a Phase I clinical study for NuQu, an injectable formulation of juvenile cartilage cells designed to treat chronic back pain caused by degenerative disc disease.